SE440450B - Forfarande for direkt framstellning av liposomer innefattande aktiva substanser - Google Patents

Forfarande for direkt framstellning av liposomer innefattande aktiva substanser

Info

Publication number
SE440450B
SE440450B SE7909282A SE7909282A SE440450B SE 440450 B SE440450 B SE 440450B SE 7909282 A SE7909282 A SE 7909282A SE 7909282 A SE7909282 A SE 7909282A SE 440450 B SE440450 B SE 440450B
Authority
SE
Sweden
Prior art keywords
phospholipid
active substances
groups
solution
extract
Prior art date
Application number
SE7909282A
Other languages
English (en)
Swedish (sv)
Other versions
SE7909282L (sv
Inventor
E Marchetti
U Bucciarelli
Original Assignee
Serono Ist Farm
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Serono Ist Farm filed Critical Serono Ist Farm
Publication of SE7909282L publication Critical patent/SE7909282L/
Publication of SE440450B publication Critical patent/SE440450B/sv

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/10—Dispersions; Emulsions
    • A61K9/127—Liposomes
    • A61K9/1277—Processes for preparing; Proliposomes
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
    • Y10T—TECHNICAL SUBJECTS COVERED BY FORMER US CLASSIFICATION
    • Y10T428/00—Stock material or miscellaneous articles
    • Y10T428/29—Coated or structually defined flake, particle, cell, strand, strand portion, rod, filament, macroscopic fiber or mass thereof
    • Y10T428/2982—Particulate matter [e.g., sphere, flake, etc.]
    • Y10T428/2984—Microcapsule with fluid core [includes liposome]

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Dispersion Chemistry (AREA)
  • Medicinal Chemistry (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Preparation (AREA)
  • Cosmetics (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
SE7909282A 1978-11-17 1979-11-09 Forfarande for direkt framstellning av liposomer innefattande aktiva substanser SE440450B (sv)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
IT51947/78A IT1111367B (it) 1978-11-17 1978-11-17 Processo per la preparazione estemporanea di liposomi e liposomi cosi' ottenuti

Publications (2)

Publication Number Publication Date
SE7909282L SE7909282L (sv) 1980-05-18
SE440450B true SE440450B (sv) 1985-08-05

Family

ID=11276064

Family Applications (1)

Application Number Title Priority Date Filing Date
SE7909282A SE440450B (sv) 1978-11-17 1979-11-09 Forfarande for direkt framstellning av liposomer innefattande aktiva substanser

Country Status (10)

Country Link
US (1) US4308166A (es)
AR (1) AR219840A1 (es)
CH (1) CH643141A5 (es)
DE (1) DE2946601C2 (es)
ES (1) ES486055A1 (es)
FR (1) FR2441385A1 (es)
GB (1) GB2035947B (es)
IL (1) IL58584A (es)
IT (1) IT1111367B (es)
SE (1) SE440450B (es)

Families Citing this family (41)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4394372A (en) * 1980-12-22 1983-07-19 The Procter & Gamble Company Process for making lipid membrane structures
US4551288A (en) * 1982-08-16 1985-11-05 Sandoz, Inc. Processes for the preparation of liposome drug delivery systems
GB2134869A (en) * 1983-02-15 1984-08-22 Squibb & Sons Inc Method of preparing liposomes and products produced thereby
GB2135647A (en) * 1983-02-15 1984-09-05 Squibb & Sons Inc Method of preparing liposomes and products produced thereby
FR2543018B1 (fr) * 1983-03-22 1985-07-26 Oreal Procede de preparation de vesicules lipidiques par vaporisation de solvants
US4622219A (en) * 1983-06-17 1986-11-11 Haynes Duncan H Method of inducing local anesthesia using microdroplets of a general anesthetic
FR2553002B1 (fr) * 1983-10-06 1992-03-27 Centre Nat Rech Scient Procede perfectionne d'obtention de liposomes unilamellaires de diametres eleves, leur application pharmacologique pour l'encapsulage d'un principe actif en vue de son administration extemporanee et dispositif correspondant
US5008050A (en) * 1984-06-20 1991-04-16 The Liposome Company, Inc. Extrusion technique for producing unilamellar vesicles
US5059421A (en) * 1985-07-26 1991-10-22 The Liposome Company, Inc. Preparation of targeted liposome systems of a defined size distribution
US5230899A (en) * 1985-08-07 1993-07-27 Smithkline Beecham Corporation Methods and compositions for making liposomes
DE3683487D1 (de) * 1985-10-21 1992-02-27 Liposome Co Inc In situ-herstellung und verabreichung von liposomen.
US4812314A (en) * 1986-02-24 1989-03-14 Yissum Research & Dev. Co. Of The Hebrew Univ. Of Jerusalem And Hadassah Medical Organization Lipid replacement therapy
EP0293465B1 (en) * 1986-11-28 1992-03-18 The Liposome Company, Inc. Phospholipid composition
US4950432A (en) * 1987-10-16 1990-08-21 Board Of Regents, The University Of Texas System Polyene microlide pre-liposomal powders
US5269979A (en) * 1988-06-08 1993-12-14 Fountain Pharmaceuticals, Inc. Method for making solvent dilution microcarriers
US5133965A (en) * 1988-06-08 1992-07-28 Fountain Pharmaceuticals, Inc. Dressing material having adsorbed thereon a solvent dilution microcarrier precursor solution
US5073543A (en) * 1988-07-21 1991-12-17 G. D. Searle & Co. Controlled release formulations of trophic factors in ganglioside-lipsome vehicle
US5622715A (en) * 1994-06-10 1997-04-22 Yissum Research Development Company Of The Hebrew University Of Jerusalem Method of improving renal function
US6235308B1 (en) 1994-06-10 2001-05-22 Yissum Research Development Company Of The Hebrew University Of Jerusalem Method of treating hypertension
AU709262B2 (en) * 1995-10-17 1999-08-26 Board Of Regents, The University Of Texas System Insoluble drug delivery
US7255877B2 (en) 1996-08-22 2007-08-14 Jagotec Ag Fenofibrate microparticles
US6465016B2 (en) 1996-08-22 2002-10-15 Research Triangle Pharmaceuticals Cyclosporiine particles
US5891467A (en) 1997-01-31 1999-04-06 Depotech Corporation Method for utilizing neutral lipids to modify in vivo release from multivesicular liposomes
WO1999040906A2 (en) * 1998-02-11 1999-08-19 Research Triangle Pharmaceuticals Method and composition for treatment of inflammatory conditions
US6979456B1 (en) 1998-04-01 2005-12-27 Jagotec Ag Anticancer compositions
ATE259220T1 (de) 1998-05-29 2004-02-15 Skyepharma Canada Inc Gegen hitzeeinwirkung geschützte mikropartikel und verfahren zur terminalen dampfsterilisation derselben
US7097849B2 (en) 1998-08-19 2006-08-29 Jagotec Ag Injectable aqueous dispersions of propofol
RU2233654C2 (ru) 1998-11-20 2004-08-10 Ртп Фарма Инк. Диспергируемые стабилизированные фосфолипидом микрочастицы
ES2469642T3 (es) 2000-04-20 2014-06-18 Jagotec Ag Procedimiento mejorado para partículas de fármaco insoluble en agua
US6634576B2 (en) 2000-08-31 2003-10-21 Rtp Pharma Inc. Milled particles
US8586094B2 (en) 2000-09-20 2013-11-19 Jagotec Ag Coated tablets
BRPI0105509B8 (pt) * 2001-11-05 2021-05-25 Univ Minas Gerais formulações do peptídeo angiotensina-(1-7) usando as ciclodextrinas, lipossomas e o polímero plga
JP5502480B2 (ja) 2006-09-18 2014-05-28 コンピュゲン エルティーディー． 生物活性ペプチド及びその使用方法
US8492329B2 (en) 2007-07-12 2013-07-23 Compugen Ltd. Bioactive peptides and methods of using same
ES2916498T3 (es) 2007-12-06 2022-07-01 Genalyte Inc Método para identificar una secuencia de nucleótidos en una especie desconocida de ácido nucleico; y dispositivo para llevar a cabo el método
WO2010062627A2 (en) 2008-10-27 2010-06-03 Genalyte Inc. Biosensors based on optical probing and sensing
US9921165B2 (en) 2010-11-05 2018-03-20 Genalyte, Inc. Optical analyte detection systems and methods of use
JP2014510045A (ja) 2011-02-08 2014-04-24 ハロザイム インコーポレイテッド ヒアルロナン分解酵素の組成物および脂質製剤ならびに良性前立腺肥大症の治療のためのその使用
EP3907506A1 (en) 2012-03-12 2021-11-10 The Board of Trustees of the University of Illinois Optical analyte detection systems with magnetic enhancement and methods of their use
HUE043847T2 (hu) 2014-08-28 2019-09-30 Halozyme Inc Hialuronán-lebontó enzimmel és egy immun checkpoint inhibitorral végzett kombinációs terápia
US10429302B2 (en) 2015-08-11 2019-10-01 Scintillon Institute For Biomedical And Bioenergy Research Optical analyses of particles and vesicles

Family Cites Families (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3009856A (en) * 1954-12-14 1961-11-21 Armour & Co Adrenocorticotrophin and vitamin b compositions
DE2249552A1 (de) * 1971-10-12 1973-05-30 Inchema S A Verfahren zur inkapsulation von insbesondere wasserloeslichen verbindungen
US3932657A (en) * 1973-11-12 1976-01-13 The United States Of America As Represented By The United States Energy Research And Development Administration Liposome encapsulation of chelating agents
US3993754A (en) * 1974-10-09 1976-11-23 The United States Of America As Represented By The United States Energy Research And Development Administration Liposome-encapsulated actinomycin for cancer chemotherapy
JPS5186117A (en) * 1975-01-27 1976-07-28 Tanabe Seiyaku Co Johoseibiryushiseizainoseiho
DE2538678A1 (de) * 1975-08-30 1977-03-03 Boehringer Mannheim Gmbh Injizierbare loesungen
GB1523965A (en) * 1976-03-19 1978-09-06 Ici Ltd Pharmaceutical compositions containing steroids
GB1575343A (en) * 1977-05-10 1980-09-17 Ici Ltd Method for preparing liposome compositions containing biologically active compounds
CH624011A5 (es) * 1977-08-05 1981-07-15 Battelle Memorial Institute

Also Published As

Publication number Publication date
DE2946601C2 (de) 1990-05-31
GB2035947B (en) 1982-12-01
FR2441385B1 (es) 1983-04-08
DE2946601A1 (de) 1980-05-29
ES486055A1 (es) 1980-09-01
FR2441385A1 (fr) 1980-06-13
GB2035947A (en) 1980-06-25
IT1111367B (it) 1986-01-13
AR219840A1 (es) 1980-09-15
IL58584A0 (en) 1980-01-31
SE7909282L (sv) 1980-05-18
IL58584A (en) 1982-08-31
CH643141A5 (de) 1984-05-30
US4308166A (en) 1981-12-29
IT7851947A0 (it) 1978-11-17

Similar Documents

Publication Publication Date Title
SE440450B (sv) Forfarande for direkt framstellning av liposomer innefattande aktiva substanser
CA2232541C (en) Fractionated vegetable oil
EP0088046B1 (de) Lipide in wässriger Phase
DE69626927T2 (de) Oleat Monoester von Estrogenen zur Behandlung von Fettleibigkeit
US4372949A (en) Treatment of cancer with carcinostatic and immunostimulating agent containing lysophospholipid and phospholipid
Hery et al. Participation of serotonin in the phasic release of luteinizing hormone. II. Effects of lesions of serotonin-containing pathways in the central nervous system
CLAESSON et al. The Formation Mechanism of Oestrogenic Hormones: The Presence of an Oestrogen‐Precursor in the Rabbit Ovary 1
DK175504B1 (da) Farmaceutisk præparat indeholdende 3alfa-hydroxy-5beta-pregnan-20-on og fremstilling deraf
Willner et al. N-methyl-D-aspartate antagonist D-APV selectively disrupts taste-potentiated odor aversion learning.
Eden et al. Hydrolysis and esterification of vitamin A during absorption
Evans et al. Soybean “lecithin” and its fractions as metal‐inactivating agents
Singh et al. Effect of two pesticides on total lipid and cholesterol contents of ovary, liver and blood serum during different phases of the annual reproductive cycle in the freshwater teleost Heteropneustes fossilis (Bloch)
Ayyad et al. Palmitic acid enhances cholesterol gallstone incidence in Sasco hamsters fed cholesterol enriched diets
EP1289530B1 (en) Lipids for modulating immune response
CA2083723A1 (en) Process for removing sterols from vegetable and animal fat
KR19990076946A (ko) 안티글루코코르티코이드 약제
WO1989005655A1 (en) Dietary supplement and method for the treatment of menopause and manifestations of aging
WO1995017897A1 (en) Non-methylene interrupted fatty acids as immunomodulators
FLEISCHMANN* The use of colchicine in the assay of androgens
RU2304000C1 (ru) Способ получения диагностического аллергена
Waters The extraction of lipids from human plasma or serum by 2-octanol
Goldstein et al. Experimental allergic encephalomyelitis following administration of homologous brain lipid fractions
BE882048A (fr) Agent carcinostatique et immunostimulant contenant un lysophospholipide et un phospholipide et procede pour le preparer
Morin et al. Possible implication of lysophosphatidylcholine in cell fusion accompanying implantation in rabbits
Smotherman et al. Behavioral and corticosterone effects in conditioned taste aversion following hippocampal lesions

Legal Events

Date Code Title Description
NAL Patent in force

Ref document number: 7909282-1

Format of ref document f/p: F

NUG Patent has lapsed

Ref document number: 7909282-1

Format of ref document f/p: F